Harvard and the Brigham investigating leading heart group for “compromised” data

circulationcoverCirculation has retracted a 2012 study by a group of Harvard heart specialists over concerns of corrupt data, and the university is investigating. The group was led by Piero Anversa, a leading cardiologist, and Joseph Loscalzo — who will be familiar to readers of Circulation as the editor in chief of that journal. (Anversa’s also on the editorial board).

Continue reading Harvard and the Brigham investigating leading heart group for “compromised” data

Nature paper retracted following multiple failures to reproduce results

nature 2-27-14An international team of researchers from the NIH, Harvard, the University of Michigan, and two Chinese universities — Fourth Military Medical University and China Medical University — has retracted their 2012 paper in Nature after they — and a number of other groups — were unable to reproduce the key results.

The original abstract for “The NAD-dependent deacetylase SIRT2 is required for programmed necrosis” said that the findings

implicate SIRT2 as an important regulator of programmed necrosis and indicate that inhibitors of this deacetylase may constitute a novel approach to protect against necrotic injuries, including ischaemic stroke and myocardial infarction.

But here’s the notice, by corresponding author Toren Finkel and colleagues: Continue reading Nature paper retracted following multiple failures to reproduce results

Blood retracts two red cell illustrations that “could have misled” readers

blood cover214Blood has retracted two 2013 illustrations of red cells by researchers from South Africa and the United States because, somewhat confusingly, they didn’t conform to the journal’s criteria for publishing such material.

Here’s the notice for one of the images, “Red blood cell and platelet interactions in healthy females during early and late pregnancy, as well as postpartum”: Continue reading Blood retracts two red cell illustrations that “could have misled” readers

Harvard student publication retracts article saying Jews deserve punishment because “they killed Jesus”

ichthusA Harvard student publication has retracted an article arguing that Jews deserved the persecution they’ve received for 2,000 years because they “killed Jesus.”

(We’ll do a few conflict of interest disclosures, if just for the hell — oops — of it: Harvard is Ivan’s alma mater, and both of us are well, Jews. We note, however, that the Ichthus was not around in Ivan’s Harvard days, and neither of us was around when the events involving Jesus described in this post occurred.)

As Talking Points Memo reported Thursday: Continue reading Harvard student publication retracts article saying Jews deserve punishment because “they killed Jesus”

Retraction appears for Harvard scientist who had two mega-corrections last year

molecular cellSam Lee, a Harvard biologist who had two mega-corrections published last year, has retracted a paper in Molecular Cell because some of the figures were “inappropriately assembled.”

Here’s the notice for “GAMT, a p53-Inducible Modulator of Apoptosis, Is Critical for the Adaptive Response to Nutrient Stress:” Continue reading Retraction appears for Harvard scientist who had two mega-corrections last year

Two retractions appear for former Harvard dental researcher found to have committed misconduct

Martin
Martin Biosse-Duplan

Martin Biosse-Duplan, a former Harvard dental school research fellow found by the Office of Research Integrity to have falsified results has had the two papers in question retracted.

From the Journal of Bone and Mineral Research: Continue reading Two retractions appear for former Harvard dental researcher found to have committed misconduct

Former Harvard dental school researcher committed misconduct: ORI

Martin Biosse-Duplan
Martin Biosse-Duplan

Last week was a busy one at the U.S. Office of Research Integrity (ORI), at least judging by how many cases they posted. There were sanctions against researchers at Ohio State, Texas Tech, and the Gladstone Institutes, as we reported. And it turns out there was another case closed, of a former Harvard dental school research fellow, The Scientist reports.

According to the ORI, Martin Biosse-Duplan “engaged in research misconduct in research supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), grant R01 AR054450.”

The misconduct involved a lab presentation and two published abstracts: Continue reading Former Harvard dental school researcher committed misconduct: ORI

Poignancy in physics: Retraction for “fatal error” that couldn’t be patched

prl-bannerIn August of last year, Mladen Pavičić, chair of physics at the University of Zagreb’s Faculty of Civil Engineering, published a paper in Physical Review Letters on quantum teleportation, “Near-Deterministic Discrimination of All Bell States with Linear Optics.”

Just six days later, after hearing from a physicist in China, Pavičić — who is also affiliated with Harvard’s physics department — submitted a correction, which ran on the journal’s site in November. The correction begins: Continue reading Poignancy in physics: Retraction for “fatal error” that couldn’t be patched

Image correction in Current Biology for Harvard’s Sam Lee

The work of Sam W. Lee, a cancer biologist at Harvard and Massachusetts General Hospital, has come under fire at Science Fraud lately over concerns about the possible reuse of images in his group’s published studies.

Turns out there’s some there, there after all. The journal Current Biology has issued a pretty thorny correction for one of Lee’s 2006 articles, “RhoE Is a Pro-Survival p53 Target Gene that Inhibits ROCK I-Mediated Apoptosis in Response to Genotoxic Stress,” citing multiple issues with its figures: Continue reading Image correction in Current Biology for Harvard’s Sam Lee

JAMA’s first-ever Expression of Concern appears for hip protector study

JAMA has issued its first-ever Expression of Concern over a 2007 study of hip protectors in the elderly that came under scrutiny from Federal regulators.

As the Boston Globe was first to report yesterday, the journal’s editor and executive deputy editor wrote in a notice published online: Continue reading JAMA’s first-ever Expression of Concern appears for hip protector study